What You Need to Know About Canine Osteoarthritis and the Canine Osteoarthritis Staging Tool with Dr. David Dycus | VETgirl Veterinary Continuing Education Podcasts

March 2024

In today’s VETgirl online veterinary CE podcast, we talk to Dr. David Dycus, MS, CCRP, DACVS about what you need to know about managing canine osteoarthritis (OA), how it affects our canine patient’s quality of life, and what we can do about it. Tune in to learn about the Canine Osteoarthritis Staging Tool (COAST), how it affects our veterinary patient outcomes, and what to do if you’re hesitant to use NSAIDs long term! What role do anti-NGF monoclonal antibody products (e.g., Librela) have for the treatment of OA?


Mosley C, Edwards T, Romano L, et al. Proposed Canadian Consensus Guidelines on Osteoarthritis Treatment Based on OA-COAST Stages 1-4. Front Vet Sci 2022;26:9:830098. doi: 10.3389/fvets.2022.830098.

Cachon T, Frykman O, Innes JF, et al. COAST Development Group’s international consensus guidelines for the treatment of canine osteoarthritis. Front Vet Sci 2023;10. doi.org/10.3389/fvets.2023.1137888.

Today’s VETgirl podcast is brought to you by Elanco, makers of Galliprant. Galliprant doesn’t just mask pain, it is specifically designed to treat joint inflammation and pain associated with canine osteoarthritis, without any tradeoffs. Effectively control canine OA inflammation and pain with the precision power of Galliprant®. For more information, visit https://my.elanco.com/us/galliprant.

galliprant logo

Today’s VETgirl podcast is sponsored by Elanco. Please note the opinions in this podcast are the expressed opinion of the speaker(s)/sponsor, and not directly endorsed by VETgirl.

Please note: Dr. Dycus has been compensated for his participation in this podcast.

Only VETgirl members can leave comments. Sign In or Join VETgirl now!